Evidence map›Paper›PMID 25942481›Full record

ArticleThe Journal of clinical endocrinology and metabolism2015

CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency.

Tom D Thacher, Philip R Fischer, Ravinder J Singh, Jeffrey Roizen, Michael A Levine

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03384121 (Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia), which is not on this map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03384121 phase1unknown statusnot on this mapstarted 2018, after this paper: background citation

Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Idiopathic Infantile Hypercalcemia

TypeinterventionalSponsorThe Hospital for Sick ChildrenRan2018 to 2021Enrolled5ConditionsIdiopathic Infantile Hypercalcemia - Mild FormArmsRifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Novel Mutation inJCEM case reports · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Tom D ThacherDepartment of Family Medicine (T.D.T.), Jos University Teaching Hospital, Jos, Nigeria 930241; Department of Family Medicine (T.D.T.), Department of Pediatric and Adolescent Medicine (P.R.F.), and Department of Laboratory Medicine and Pathology (R.J.S.), Mayo Clinic, Rochester, Minnesota 55905; and The Children's Hospital of Philadelphia and Department of Pediatrics (J.R., M.A.L.), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104.
Philip R FischerDepartment of Family Medicine (T.D.T.), Jos University Teaching Hospital, Jos, Nigeria 930241; Department of Family Medicine (T.D.T.), Department of Pediatric and Adolescent Medicine (P.R.F.), and Department of Laboratory Medicine and Pathology (R.J.S.), Mayo Clinic, Rochester, Minnesota 55905; and The Children's Hospital of Philadelphia and Department of Pediatrics (J.R., M.A.L.), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104.
Ravinder J SinghDepartment of Family Medicine (T.D.T.), Jos University Teaching Hospital, Jos, Nigeria 930241; Department of Family Medicine (T.D.T.), Department of Pediatric and Adolescent Medicine (P.R.F.), and Department of Laboratory Medicine and Pathology (R.J.S.), Mayo Clinic, Rochester, Minnesota 55905; and The Children's Hospital of Philadelphia and Department of Pediatrics (J.R., M.A.L.), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104.
Jeffrey RoizenDepartment of Family Medicine (T.D.T.), Jos University Teaching Hospital, Jos, Nigeria 930241; Department of Family Medicine (T.D.T.), Department of Pediatric and Adolescent Medicine (P.R.F.), and Department of Laboratory Medicine and Pathology (R.J.S.), Mayo Clinic, Rochester, Minnesota 55905; and The Children's Hospital of Philadelphia and Department of Pediatrics (J.R., M.A.L.), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104.
Michael A LevineDepartment of Family Medicine (T.D.T.), Jos University Teaching Hospital, Jos, Nigeria 930241; Department of Family Medicine (T.D.T.), Department of Pediatric and Adolescent Medicine (P.R.F.), and Department of Laboratory Medicine and Pathology (R.J.S.), Mayo Clinic, Rochester, Minnesota 55905; and The Children's Hospital of Philadelphia and Department of Pediatrics (J.R., M.A.L.), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104.
Children's Hospital of Philadelphia · USMayo Clinic · USUniversity of Minnesota Rochester · USUniversity of Pennsylvania · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
T32 Institutional Pediatric ResearchT32HD043021 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI Joseph W. St. Geme · 2002 to 2026
$6.4M
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1R01DK112955 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI Michael A. Levine, David R Weber · 2017 to 2026
$5.1M
Career Development Program in Pediatric Diabetes Research (K12) at CHOPK12DK094723 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI WILLI, STEVEN M · 2011 to 2020
$3.6M
The Role of GCM2 in Parathyroid Gland HomeostasisR01DK079970 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI LEVINE, MICHAEL A. · 2009 to 2015
$3.2M
Investigation of Hypercalciuria as a Cause of Impaired Bone Mineral Accrual in Type 1 DiabetesK23DK114477 · NIDDK · UNIVERSITY OF ROCHESTER · PI WEBER, DAVID R · 2017 to 2019
$573k
NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1TR000003NICHD NIH HHS T32 HD043021NICHD NIH HHS T32-HD043021NIDDK NIH HHS K12 DK094723NIDDK NIH HHS K23 DK114477NIDDK NIH HHS R01 DK079970NIDDK NIH HHS R01DK079970NIDDK NIH HHS R01 DK112955
6 · The paper itself

Abstract

contextProduction of the active vitamin D hormone 1,25-dihydroxyvitamin D requires hepatic 25-hydroxylation of vitamin D. The CYP2R1 gene encodes the principal vitamin D 25-hydroxylase in humans.

objectiveThis study aimed to determine the prevalence of CYP2R1 mutations in Nigerian children with familial rickets and vitamin D deficiency and assess the functional effect on 25-hydroxylase activity. DESIGN AND

participantsWe sequenced the CYP2R1 gene in subjects with sporadic rickets and affected subjects from families in which more than one member had rickets.

main outcome measuresFunction of mutant CYP2R1 genes as assessed in vivo by serum 25-hydroxyvitamin D values after administration of vitamin D and in vitro by analysis of mutant forms of the CYP2R1.

resultsCYP2R1 sequences were normal in 27 children with sporadic rickets, but missense mutations were identified in affected members of 2 of 12 families, a previously identified L99P, and a novel K242N. In silico analyses predicted that both substitutions would have deleterious effects on the variant proteins, and in vitro studies showed that K242N and L99P had markedly reduced or complete loss of 25-hydroxylase activity, respectively. Heterozygous subjects were less affected than homozygous subjects, and oral administration of vitamin D led to significantly lower increases in serum 25-hydroxyvitamin D in heterozygous than in control subjects, whereas homozygous subjects showed negligible increases.

conclusionThese studies confirm that CYP2R1 is the principal 25-hydroxylase in humans and demonstrate that CYP2R1 alleles have dosage-dependent effects on vitamin D homeostasis. CYP2R1 mutations cause a novel form of genetic vitamin D deficiency with semidominant inheritance.

Indexed as

Mutation, MissenseAdolescentAdultBase SequenceChildChild, PreschoolCholestanetriol 26-MonooxygenaseCohort StudiesCytochrome P450 Family 2FamilyHumansInfantMiddle AgedNigeriaPedigreePolymorphism, Single Nucleotide25-hydroxyvitamin DCholestanetriol 26-MonooxygenaseCYP2R1 protein, humanCytochrome P450 Family 2Vitamin D

Identifiers

PMID25942481
PMCPMC4490307
OpenAlexW1917138589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.